Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia

Launched by DELTA UNIVERSITY FOR SCIENCE AND TECHNOLOGY · Aug 4, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called cryotherapy to help children who have cancer, specifically leukemia, and are experiencing a painful condition known as chemotherapy-induced peripheral neuropathy. This condition can cause tingling, numbness, or pain in the hands and feet due to the side effects of chemotherapy. The study will involve children aged 8 to 17 years who are currently undergoing chemotherapy and have symptoms of peripheral neuropathy caused by the treatment.

To participate in this trial, children must be between 8 and 17 years old, and they should be receiving chemotherapy as part of their cancer treatment. However, some children won't be eligible, such as those with epilepsy, blood clotting disorders, open wounds, severe heart issues, or those who may not be able to cooperate during the study. If involved in the trial, participants can expect to receive cryotherapy, which involves applying cold to the affected areas, to see if it helps reduce their symptoms. This is an exciting opportunity for young patients to potentially find relief from discomfort related to their cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Their age will ranging from eight to seventeen years.
• • 2. Children participated in this study will from both sexes.
• • 3. Children receiving chemotherapy as medical treatment protocol
• • 4. All children have polyneuropathy caused by chemotherapy.
• Exclusion Criteria:
• • 1. Children with Epilepsy.
• • 2. Children with blood clotting disorder.
• • 3. Children have Open wounds / broken skin
• • 4. Children with severe cardiac disease
• • 5. Uncooperative patients.